Overall, the analyst is optimistic about Viking’s prospects, maintaining the stock as a top pick for 2025 and an Outperform rating on its shares. Price Action: VKTX stock is down 11.4% at $41.37 ...

Shares of Viking Therapeutics (VKTX) are down $2.70, or 6%, to $44.00 in pre-market trading following Merck (MRK) and Chinese biopharmaceutical company Hansoh Pharma’s announcement earlier that ...

Recognized for their exceptional products, Viking provides free standing ranges, range tops, ovens, refrigeration of all kinds, and much more. They have re-engineered their products and they are ...

Create an account or log in to save stories. Pro Football Hall of Fame wide receiver Randy Moss said Friday he is being treated for cancer and is recovering from major surgery. In an appearance on ...

Barclays analyst Brandt Montour downgraded Viking Holdings (VIK) to Equal Weight from Overweight with an unchanged price target of $49. The firm cites the stock’s recent rally for the downgrade.